KR20070049962A - 경구 고형 제제 및 그의 제조 방법 - Google Patents
경구 고형 제제 및 그의 제조 방법 Download PDFInfo
- Publication number
- KR20070049962A KR20070049962A KR1020060107016A KR20060107016A KR20070049962A KR 20070049962 A KR20070049962 A KR 20070049962A KR 1020060107016 A KR1020060107016 A KR 1020060107016A KR 20060107016 A KR20060107016 A KR 20060107016A KR 20070049962 A KR20070049962 A KR 20070049962A
- Authority
- KR
- South Korea
- Prior art keywords
- ibuprofen
- oral solid
- caffeine
- powder
- cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (6)
- 이부프로펜, 카페인, 결정 셀룰로오스 및 수용성 고분자를 습식 조립 후, 건조하여 얻어진 경구 고형 제제.
- 제 1항에 있어서, 수용성 고분자가, 히드록시프로필셀룰로오스, 히드록시프로필메틸셀룰로오스, 카르복시메틸셀룰로오스 나트륨, 메틸셀룰로오스, 아라비아 검, 폴리비닐피롤리돈, 덱스트린, 알긴산나트륨 및 카제인으로부터 선택되는 1종 또는 2종이상인 경구 고형 제제.
- 제 1항에 있어서, 이부프로펜이 평균 입경 50∼500㎛의 분말인 경구 고형 제제.
- 제 1항에 있어서, 카페인이 평균 입경 1∼180㎛의 분말인 경구 고형 제제.
- 제 1항에 있어서, 이부프로펜, 카페인, 결정 셀룰로오스 및 수용성 고분자의 비율이 100: 5∼500: 1∼5000: 0.1∼8000 질량부인 기재의 경구 고형 제제.
- 이부프로펜, 카페인, 결정 셀룰로오스 및 수용성 고분자를 습식 조립 후, 건조하는 것을 특징으로 하는 경구 고형 제제의 제조법.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005324968A JP2007131561A (ja) | 2005-11-09 | 2005-11-09 | 経口固形製剤及びその製造法 |
| JPJP-P-2005-00324968 | 2005-11-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20070049962A true KR20070049962A (ko) | 2007-05-14 |
Family
ID=38074929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020060107016A Ceased KR20070049962A (ko) | 2005-11-09 | 2006-11-01 | 경구 고형 제제 및 그의 제조 방법 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2007131561A (ko) |
| KR (1) | KR20070049962A (ko) |
| CN (1) | CN1965836B (ko) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210369618A1 (en) * | 2018-11-16 | 2021-12-02 | Ssp Co., Ltd. | Ibuprofen-containing oral pharmaceutical formulation |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011274909B2 (en) * | 2010-07-09 | 2014-09-11 | Suntory Holdings Limited | Carbonated drinks containing caffeine |
| JP2012095616A (ja) * | 2010-11-04 | 2012-05-24 | Kao Corp | 苦味抑制剤 |
| WO2013140972A1 (ja) * | 2012-03-23 | 2013-09-26 | 大正製薬株式会社 | 炭酸飲料 |
| JP6554839B2 (ja) * | 2014-04-02 | 2019-08-07 | 大正製薬株式会社 | 経口用組成物 |
| CN105249439A (zh) * | 2015-11-10 | 2016-01-20 | 朱丽芬 | 一种具有抗氧化功能的粘性糖粉 |
| RS62518B1 (sr) * | 2015-11-18 | 2021-11-30 | Hermes Pharma Gmbh | Kompozicije ibuprofena za direktno oralno davanje |
| CN111093379A (zh) * | 2017-09-29 | 2020-05-01 | 雀巢产品有限公司 | 咖啡因生产方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08333265A (ja) | 1995-06-07 | 1996-12-17 | Taisho Pharmaceut Co Ltd | イブプロフェン懸濁液剤 |
| JPH09208458A (ja) * | 1996-02-02 | 1997-08-12 | Ss Pharmaceut Co Ltd | 不快な味がマスキングされた製剤 |
| US5904937A (en) * | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
| JPH11193230A (ja) * | 1997-12-26 | 1999-07-21 | Takeda Chem Ind Ltd | 放出制御製剤 |
| JP5248733B2 (ja) * | 2003-11-28 | 2013-07-31 | エスエス製薬株式会社 | 揮散防止型固形製剤およびその製造方法 |
-
2005
- 2005-11-09 JP JP2005324968A patent/JP2007131561A/ja active Pending
-
2006
- 2006-11-01 KR KR1020060107016A patent/KR20070049962A/ko not_active Ceased
- 2006-11-08 CN CN200610146455XA patent/CN1965836B/zh not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210369618A1 (en) * | 2018-11-16 | 2021-12-02 | Ssp Co., Ltd. | Ibuprofen-containing oral pharmaceutical formulation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1965836A (zh) | 2007-05-23 |
| HK1100352A1 (en) | 2007-09-21 |
| JP2007131561A (ja) | 2007-05-31 |
| CN1965836B (zh) | 2011-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2184570C2 (ru) | Препараты для орального введения | |
| JP4365106B2 (ja) | 医薬配合剤 | |
| Pahwa et al. | Superdisintegrants in the development of orally disintegrating tablets: a review | |
| JP4365107B2 (ja) | 医薬組成物 | |
| US20020022057A1 (en) | Oral delivery of pharmaceuticals via encapsulation | |
| Renu et al. | Chewable tablets: a comprehensive review | |
| KR20090113777A (ko) | 불쾌한 맛을 은폐한 경구 조성물 | |
| SK74496A3 (en) | Organoleptically acceptable oral pharmaceutical compositions | |
| KR101203186B1 (ko) | 약물의 맛이 차폐된 경구용 약학 조성물 및 그 제조 방법 | |
| US20070154549A1 (en) | Multiparticulate formulations for oral delivery | |
| SK74396A3 (en) | Organoleptically acceptable oral pharmaceutical compositions | |
| JP2010270019A (ja) | 固形内服薬組成物 | |
| US20150072014A1 (en) | Pharmaceutical Compositions of Sodium Picosulfate, Magnesium Oxide and Citric Acid | |
| KR20070049962A (ko) | 경구 고형 제제 및 그의 제조 방법 | |
| JP2004269513A (ja) | 固形製剤 | |
| CN102258490B (zh) | 布洛芬咀嚼片 | |
| JPH1135486A (ja) | 薬用固形製剤 | |
| RU2166937C1 (ru) | Лекарственное средство на основе парацетамола | |
| CN1330378C (zh) | 药物组合物 | |
| JP3778240B2 (ja) | 不快な味がマスキングされた造粒組成物及びその製造方法 | |
| JPWO2006129668A1 (ja) | 糖衣を施した丸剤 | |
| JP7709812B1 (ja) | 固形組成物 | |
| JP2012070675A (ja) | 打錠用粉末ガム及び打錠チューインガム | |
| HK1100352B (en) | Solid medicament of oral administration and preparation thereof | |
| Namdev et al. | Unexplored Potential of Medicated Candies And Lozenges as a Drug Delivery System |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20061101 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20110810 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20061101 Comment text: Patent Application |
|
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20130328 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20130813 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20130328 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |